EUVIMEDEUVIMED entdecken
Crossref

Coagulation Factor Consumption and Medium‐ to Long‐Term Outcomes of Achilles Tendon Lengthening With and Without External Fixation in Haemophilia

Ze Chen, Guiyong Jiang, Yaowen Xu, Jiaxin Lv, Haihao Liu, Ying Wang, Weiyu Han, Bin Chen

Haemophilia · 2026

DOI: 10.1111/hae.70166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haemophilia, 2026. Verfasst von Ze Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Achilles Tendon, Hemophilia A, Blood Coagulation Factors, External Fixators. Die Arbeit nennt 31 Literaturangaben. Gefördert von: the Clinical Research Program of Southern Medical University, the Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Educat…, the Medical Scientific Research Foundation of Guangdong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Achilles tendon lengthening combined with external fixation (EF) has shown promising outcomes in managing haemophilia‐related Achilles tendon contracture.

Aim

To compare coagulation factor consumption and medium‐ to long‐term outcomes between Achilles tendon lengthening with and without EF.

Methods

Clinical data between December 2012 and April 2023 were retrospectively analysed. Patients were divided into the traditional surgery (TS) group and the EF group based on the fixation method. Inter‐group comparisons were performed ( p < 0.05 considered significant).

Results

A total of 10 patients completed follow‐up. The mean age was 25.8 ± 14.1 years, and the median follow‐up duration was 3.17 [1.78, 12.1] years. During hospitalization, mean coagulation factor consumption was lower in the EF group (19.7 ± 11.9 vs. 31.5 ± 9.31 IU/kg*day). One‐month post‐discharge, consumption was similar (25.2 ± 2.61 vs. 22.3 ± 1.06 IU/kg*day). By the second month, the EF group showed lower consumption (14.3 [13.9, 23.8] vs. 22.6 [20.8, 23.1] IU/kg*day). Additionally, mean intraoperative blood loss was lower in the EF group (104 ± 109 vs. 207 ± 101 mL). The EF group required longer mean fixation times (99 [72.0, 104] vs. 44 [42.0, 54.0] days) and showed a higher complication rate (80% vs. 40%), but all resolved or without impact on daily life. However, one case of contracture recurrence occurred in the TS group. Satisfaction and improvement rates were higher in the EF group (80% vs. 60%). Only the difference in mean fixation time reached statistical significance.

Conclusion

Achilles tendon lengthening with EF may be a safer and effective strategy for managing haemophilia‐related Achilles tendon contracture compared to TS. However, further studies are required to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Achilles TendonHemophilia ABlood Coagulation FactorsExternal FixatorsHumansAdultMaleRetrospective StudiesTreatment OutcomeYoung AdultFemaleAdolescent

Stichwörter der Autor:innen

Achilles tendon contracturecoagulation factorcomplicationexternal fixationhaemophiliasatisfaction

Substanzen

Blood Coagulation Factors

Autor:innen und Institutionen

  • Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Health Management, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Orthopaedics & Traumatology Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
  • The Tenth Affiliated Hospital (Dongguan People's Hospital), Southern Medical University, Dongguan, Guangdong, China.
  • Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Förderung

  • the Clinical Research Program of Southern Medical University
  • the Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Educat…
  • the Medical Scientific Research Foundation of Guangdong

Zitieren

APA

Chen, Z., Jiang, G., Xu, Y., Lv, J., Liu, H., Wang, Y., Han, W., & Chen, B. (2026). Coagulation Factor Consumption and Medium‐ to Long‐Term Outcomes of Achilles Tendon Lengthening With and Without External Fixation in Haemophilia. Haemophilia. https://doi.org/10.1111/hae.70166

Vancouver

Chen Z, Jiang G, Xu Y, Lv J, Liu H, Wang Y, et al. Coagulation Factor Consumption and Medium‐ to Long‐Term Outcomes of Achilles Tendon Lengthening With and Without External Fixation in Haemophilia. Haemophilia. 2026. doi:10.1111/hae.70166

BibTeX
@article{Chen2026,
  author = {Chen, Ze and Jiang, Guiyong and Xu, Yaowen and Lv, Jiaxin and Liu, Haihao and Wang, Ying and Han, Weiyu and Chen, Bin},
  title = {Coagulation Factor Consumption and Medium‐ to Long‐Term Outcomes of Achilles Tendon Lengthening With and Without External Fixation in Haemophilia},
  journal = {Haemophilia},
  year = {2026},
  doi = {10.1111/hae.70166}
}
Kostenlos starten →